#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Study of two initial doses of aflibercept for patients with newly diagnosed neovascular age-related macular degeneration

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria

  • Study of Surabgene Lomparvovec Compared to Ranibizumab for Adults with Wet Age-Related Macular Degeneration

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia France +7

  • A study comparing 4D-150 and aflibercept for adults with abnormal blood vessel growth in the eye due to age-related macular degeneration

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria France Germany Hungary Italy Latvia +3

  • Study of Port Delivery System with ranibizumab given every 36 weeks in patients with neovascular age-related macular degeneration

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Czechia Denmark France Germany Greece +3

  • Study of Faricimab Treatment Given Every 24 Weeks in Patients with Age-Related Macular Degeneration

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy Spain

  • Study on Long-Term Safety of Ranibizumab for Patients with Wet Age-Related Macular Degeneration Using a Port Delivery System

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium France Germany Italy Spain

  • Study on Vitrectomy, Alteplase, and Aflibercept for Patients with Wet Age-Related Macular Degeneration and Submacular Hemorrhage

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Ireland The Netherlands Poland Spain

  • Efficacy and safety of ABP 938 compared with aflibercept in participants with neovascular age‑related macular degeneration

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Hungary Latvia Lithuania Poland Slovakia +1

  • A Phase 2 Study of Aganirsen Eye Drops to Extend Intravitreal Aflibercept Injection Interval in Patients with Wet Age‑Related Macular Degeneration

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Long-term Safety and Effectiveness Evaluation of RGX-314 in Patients with Neovascular Age-related Macular Degeneration

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    France Germany Hungary Italy Spain